Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-015743
Filing Date
2023-12-04
Accepted
2023-12-04 16:30:09
Documents
1
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 form4-12042023_041202.html 4  
1 form4-12042023_041202.xml 4 7350
  Complete submission text file 0001415889-23-015743.txt   8792
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNITED THERAPEUTICS CORPORTION 1735 CONNECTICUT AVE. NW WASHINGTON DC 20009
Business Address
Giltner Richard (Reporting) CIK: 0001460472 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 231463638